https://www.news-medical.net/news/20150228/CSL-Behring-donates-protein-therapies-to-World-Federation-of-Hemophilia.aspx
CSL Behring donates protein therapies to World Federation of Hemophilia
Jun 19, 2019 - In recognition of Rare Disease Day and as part of its ongoing commitment to the global bleeding disorders community, CSL Behring announced today that it is...
csl behringprotein therapiesworld federationdonateshemophilia
https://www.protegobio.com/
Protego Bio - First-in-Class Therapies for Protein Misfolding Diseases
Protego Bio is a clinical-stage biotech developing first-in-class small molecule pharmacological chaperones for AL amyloidosis and other protein misfolding...
first inprotein misfoldingprotegobioclass
https://profiles.wustl.edu/en/publications/protein-production-is-an-early-biomarker-for-rna-targeted-therapi/
Protein production is an early biomarker for RNA-targeted therapies - WashU Research Profiles